This is a hard one to swallow.
We’ve been covering this space for nearly 30 years now so whenever we see something truly different, we sit up and take notice. Now that doesn’t mean what we’ve seen will work or be commercially successful. Rather it means someone is thinking way out of the box and not trying to build another me too wannabe product. Folks just in case you have forgotten this is called being creative and...
Are we our own worst enemy?
Today is Diabetes Alert Day which is supposed “alert” people about diabetes. Keep me in mind we also have World Diabetes Day November 14th which is appropriate as November is American Diabetes Month. Now I have no idea who comes up with these days but my personal favorite being from Chicago is July 19th National Hot Dog Day. I am not aware of a world hot dog day or month. No...
How’s that working out?
Before we begin a shout out to the San Diego State Aztecs, Miami Hurricanes, Connecticut Huskies, and the Florida Atlantic Owls you have busted millions of brackets and provided one of the most entertaining tournaments in years. Congrats and good luck in the Final Four. Now onto business and today’s business is insulin pumps or more specifically patch pumps. Check out this headline- ViCentra now offers Kaleido insulin pump in the...
Flexing their muscle
Before Medtronic imploded the company was ruthless when it came to IP. Hence the reason we are not surprised that Insulet now the market leader is doing the same thing. As everyone knows there are lots of Omnipod wannabes yep everyone wants a patch pump. Hence the reason this caught our eye: According to the Juve Patent site- “Italian company Menarini Diagnostics may no longer sell its insulin pump GlucoMen Day Pump...
The Silence makes the most noise.
This really should shock no one but it looks as though Medtronic Diabetes is about to undergo a reduction in force. Like Tandem Medtronic is having a tough time competing with Insulet. Like Tandem Medtronic management can’t adapt to the changing landscape of the insulin pump world. Like Tandem Medtronic foolishly believes that new products will come along and save the day. Meanwhile back in the Boston area the Bruins are...
What would it be like?
Now that Novo Nordisk has followed Lilly in lowering insulin prices Sanofi will surely follow and everyone can do the happy dance. The patient advocates can claim victory and set their sights on non-diabetic patients stealing from patients with diabetes. We on the other hand prefer to look ahead as the world is changing before our eyes. These cuts in the price of insulin are just the first step more...
The Class System
Before everyone gets too involved in their brackets it’s time to examine an issue that’s impacting the future of diabetes management. Unfortunately, this is not a new issue it’s just evolved over the years. For as long as we’ve been publishing there has been a very noticeable class warfare going on within the diabetes community. This goes well beyond Type 1 patients looking down on Type 2 patients believing that...